Enfermedad de Behçet asociada a HLA-B52 con compromiso multifocal del sistema nervioso central

Al-Araji, 2009, Neuro-Behçet's disease: epidemiology, clinical characteristics, and management, Lancet Neurol., 8, 192, 10.1016/S1474-4422(09)70015-8 Borhani-Haghighi, 2019, Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment, Mult Scler Relat Disord., 39, 101906, 10.1016/j.msard.2019.101906 Gur, 2020, Molecular dynamics simulations provide molecular insights into the role of HLA-B51 in Behçet's disease pathogenesis, Chem Biol Drug Des., 96, 644, 10.1111/cbdd.13658 de Menthon, 2009, HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies, Arthritis Rheum., 61, 1287, 10.1002/art.24642 Akman-Demir, 1999, Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group, Brain., 122, 2171, 10.1093/brain/122.11.2171 Alibaz-Oner, 2021, Advances in the Treatment of Behcet's Disease, Curr Rheumatol Rep., 23, 47, 10.1007/s11926-021-01011-z 1990, Criteria for diagnosis of Behçet's, disease. International Study Group for Behçet's Disease, Lancet., 335, 1078 International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD), 2014, The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity, specificity of the new criteria, J Eur Acad Dermatol Venereol., 28, 338, 10.1111/jdv.12107 Arber, 1991, Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome, Ann Rheum Dis., 50, 351, 10.1136/ard.50.6.351 Shahneh, 2013, New insights into HLA class I association to Behçet's syndrome in Iranian Azari patients, Auto Immun Highlights., 4, 101, 10.1007/s13317-013-0047-6